73 results on '"Teoh, Hwee"'
Search Results
2. Association of Cerebral Oximetry With Brain Ischemic Lesions and Functional Outcomes in Arch Repair
3. Wearable Cardiac Rhythm Monitoring Device for Detection of Postoperative Atrial Fibrillation
4. Mitral repair with leaflet preservation versus leaflet resection and ventricular reverse remodeling from a randomized trial
5. The Impact of Statins on Postdischarge Atrial Fibrillation After Cardiac Surgery: Secondary Analysis from a Randomized Trial
6. Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
7. A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery
8. Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 Months in a Randomized Trial
9. Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey
10. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
11. Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
12. Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction
13. Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity
14. Disruption of endothelial cell intraflagellar transport protein 88 exacerbates doxorubicin-induced cardiotoxicity
15. Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis
16. How I do it ─ superficial parasternal intercostal plane catheter insertion
17. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk
18. Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes
19. A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidation
20. Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
21. Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
22. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey
23. Endothelial-specific deletion of autophagy-related 7 (ATG7) attenuates arterial thrombosis in mice
24. Adiponectin limits monocytic microparticle-induced endothelial activation by modulation of the AMPK, Akt and NFκB signaling pathways
25. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes
26. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes
27. Dual antiplatelet therapy use by Canadian cardiac surgeons
28. Obesity and Atherosclerosis: Mechanistic Insights
29. The Essential Autophagy Gene ATG7 Modulates Organ Fibrosis via Regulation of Endothelial-to-Mesenchymal Transition
30. A Patient-Level Pooled Analysis of 2 Empagliflozin Trials of Left Ventricular Remodeling
31. BRCA1 shields vascular smooth muscle cells from oxidative stress
32. Autophagy gene fingerprint in human ischemia and reperfusion
33. Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease
34. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
35. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis
36. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1
37. Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?
38. Benefits of Modest Weight Loss on the Management of Type 2 Diabetes Mellitus
39. Type 2 Diabetes Mellitus Management in Canada: Is It Improving?
40. Impact of Empagliflozin on Left Ventricular Strain: Insights From the EMPA-HEART CardioLink-6 Randomized Clinical Trial
41. Assessment and Treatment of Cardiometabolic Risk in Adults at Risk for or with Type 2 Diabetes Mellitus
42. BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure
43. Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management
44. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)
45. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
46. Use of a Treatment Optimization Algorithm Involving Statin-Ezetimibe Combination Aids in Achievement of Guideline-Based Low-Density Lipoprotein Targets in Patients With Dyslipidemia at High Vascular Risk Guideline-Based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC)
47. DNA damage repair and cardiovascular diseases
48. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada
49. Usefulness of Statin–Ezetimibe Combination to Reduce the Care Gap in Dyslipidemia Management in Patients With a High Risk of Atherosclerotic Disease
50. Vascular biology of adiponectin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.